HRS4R
Vull donar
Vendrell J, Fernandez-Real JM, Gutierrez C, Zamora A, Simon I, Bardaji A, Ricart W, Richart C

A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients.

Atherosclerosis, 2003, 167, 257-264 dx.doi.org/10.1016/S0021-9150(02)00429-X
Bosch X, López De Sá E, López Sendón J, Aboal J, Miranda-Guardiola F, Bethencourt A, Rubio R, Moreno R, Martín Jadraque L, Roldán I, Calviño R, Valle V, Malpartida F

Perfil clínico, pronóstico y variabilidad en el tratamiento del síndrome coronario agudo sin elevación del segmento ST. Datos del registro PEPA.

REVISTA ESPANOLA DE CARDIOLOGIA, 2003, 56, 346-353 dx.doi.org/10.1157/13045649
Samaniego C, Fernández Real JM, Ricart W

Crisis hipercalcémica después de la administración de contraste yodado en un paciente con adenoma paratiroideo.

MEDICINA CLINICA, 2003, 120, 756-757 dx.doi.org/10.1016/S0025-7753(03)73833-0
Fernández-Real JM, Broch M, Richart C, Vendrell J, López-Bermejo A, Ricart W

CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88, 1780-1784 dx.doi.org/10.1210/jc.2002-020173
Castillo J, Moro MA, Blanco M, Leira R, Serena J, Lizasoain I, Dávalos A

The release of tumor necrosis factor-alpha is associated with ischemic tolerance in human stroke.

ANNALS OF NEUROLOGY, 2003, 54, 811-819 dx.doi.org/10.1002/ana.10765
Ricart W, Fernández-Real JM

Impacto del déficit hormonal y de los factores de riesgo cardiovascular sobre la expectativa de vida en el hipopituitarismo.

MEDICINA CLINICA, 2003, 120, 630-637 dx.doi.org/10.1157/13046928
López-Bermejo A, Khosravi J, Corless CL, Krishna RG, Diamandi A, Bodani U, Kofoed EM, Graham DL, Hwa V, Rosenfeld RG

Generation of anti-insulin-like growth factor-binding protein-related protein 1 (IGFBP-rP1/MAC25) monoclonal antibodies and immunoassay: quantification of IGFBP-rP1 in human serum and distribution in human fluids and tissues.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88, 3401-3408 dx.doi.org/10.1210/jc.2002-021315
Serena J, Dávalos A

Ictus de causa desconocida y foramen oval permeable: una nueva encrucijada.

REVISTA ESPANOLA DE CARDIOLOGIA, 2003, 56, 649-651 dx.doi.org/10.1016/S0300-8932(03)76933-4
Ramos R, Solanas P, Cordón F, Rohlfs I, Elosua R, Sala J, Masiá R, Faixedas MT, Marrugat J

Comparación de la función de Framingham original y la calibrada del REGICOR en la predicción del riesgo coronario poblacional.

MEDICINA CLINICA, 2003, 121, 521-526 dx.doi.org/10.1157/13053388
de Pablos-Velasco P, Ricart W, Monereo S, Moreno B, Marrugat J

The relation between physical activity and metabolic control in type 2 diabetes with <20 years of evolution.

Diabetes Care, 2003, 26, 1648-1650 dx.doi.org/10.2337/diacare.26.5.1648
Martí R, Fontana A, Uriz MJ, Cimino G

Quantitative assessment of natural toxicity in sponges: toxicity bioassay versus compound quantification.

JOURNAL OF CHEMICAL ECOLOGY, 2003, 29, 1307-1318 dx.doi.org/10.1023/A:1024201100811
Castillo J, Leira R, Moro MA, Lizasoain I, Serena J, Dávalos A

Neuroprotective effects of aspirin in patients with acute cerebral infarction.

NEUROSCIENCE LETTERS, 2003, 339, 248-250 dx.doi.org/10.1016/S0304-3940(03)00029-6
Marrugat J, Solanas P, D'Agostino R, Sullivan L, Ordovas J, Cordón F, Ramos R, Sala J, Masià R, Rohlfs I, Elosua R, Kannel WB

Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada.

REVISTA ESPANOLA DE CARDIOLOGIA, 2003, 56, 253-261 dx.doi.org/10.1157/13043951
Fernández-Real JM, Broch M, Vendrell J, Ricart W

Insulin resistance, inflammation, and serum fatty acid composition.

Diabetes Care, 2003, 26, 1362-1368 dx.doi.org/10.2337/diacare.26.5.1362
Serena J, Dávalos A, Segura T, Mostacero E, Castillo J

Stroke on awakening: looking for a more rational management.

CEREBROVASCULAR DISEASES, 2003, 16, 128-133 dx.doi.org/70592
Vozarova B, Fernández-Real JM, Knowler WC, Gallart L, Hanson RL, Gruber JD, Ricart W, Vendrell J, Richart C, Tataranni PA, Wolford JK

The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians

HUMAN GENETICS, 2003, 112, 409-413 dx.doi.org/10.1007/s00439-003-0912-x
Castellanos M, Leira R, Serena J, Pumar JM, Lizasoain I, Castillo J, Dávalos A

Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke.

Stroke, 2003, 34, 40-46 dx.doi.org/10.1161/01.STR.0000046764.57344.31
Martínez-Rodríguez JE, Lin L, Iranzo A, Genis D, Martí MJ, Santamaria J, Mignot E

Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.

Sleep, 2003, 26, 287-290 dx.doi.org/10.1093/sleep/26.3.287
Brugada J, Brugada P, Brugada R

Síndrome de bloqueo de rama derecha, elevación del segmento ST en las derivaciones V1 a V3 y muerte súbita.

MEDICINA CLINICA, 2002, 118, 150-156 dx.doi.org/10.1016/S0025-7753(02)72313-0
Castellanos M, Castillo J, García MM, Leira R, Serena J, Chamorro A, Dávalos A

Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target.

Stroke, 2002, 33, 982-987 dx.doi.org/10.1161/hs0402.105339

Coneix l’IDIBGI!

menu